Clinical Trials
34 trialsEQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Case Comprehensive Cancer Center
SOLO
Medical College of Wisconsin
SCOPE
Universitair Ziekenhuis Brussel
Chase
Fudan University
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
Ohio State University Comprehensive Cancer Center
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Pliant Therapeutics, Inc.
ANTARES
Instituto do Cancer do Estado de São Paulo
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
EvolveImmune United, Inc
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
Hoosier Cancer Research Network
DILANA
University Hospital Heidelberg
MAESTRO
University Health Network, Toronto
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Rutgers, The State University of New Jersey
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Rutgers, The State University of New Jersey
SMP-3124LP in Adults With Advanced Solid Tumors
Sumitomo Pharma America, Inc.
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Cedars-Sinai Medical Center
Adaptive Radiation in Anal Cancer
Columbia University
Ganglion Impar Neurolysis for the Improvement of Radiation-Induced Pain During Localized Anal or Perianal Skin Cancer Treatment
Emory University
HPVsign
ANRS, Emerging Infectious Diseases
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
University of California, San Francisco
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
LigaChem Biosciences, Inc.
DECIDE
Institut Claudius Regaud
KANALRAD
Federation Francophone de Cancerologie Digestive
SWAN
Icahn School of Medicine at Mount Sinai
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Jonsson Comprehensive Cancer Center
Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.
PCK Marine Hospital in Gdynia
Vulvar-AIN
Sunnybrook Health Sciences Centre
SWANCA
Umeå University
AMethysT
Assistance Publique - Hôpitaux de Paris
NOAC9 - Circulating Tumor DNA Guided Follow-Up in Anal Cancer
Aarhus University Hospital
SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas
The Affiliated Hospital of Qingdao University
DEP-HPV
University Hospital, Toulouse
HRYZ-T101 Injection for HPV18 Positive Solid Tumor
HRYZ Biotech Co.
SPARTANA
Centre Hospitalier Universitaire de Besancon
ReRad III
University of Aarhus